`571-272-7822
`
`
`
`
`
`
`
`
`
`
`
`
`Paper: 14
`
`
`
` Entered: October 25, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ARGENTUM PHARMACEUTICALS LLC,
`
`Petitioner,
`
`v.
`
`ALCON RESEARCH, LTD.,
`
`Patent Owner.
`_______________
`
`Case IPR2017-01053
`Patent 8,268,299 B2
`_______________
`
`
`
`Before RICHARD E. SCHAFER, GRACE KARAFFA OBERMANN,
`and SUSAN L. C. MITCHELL, Administrative Patent Judges.
`
`
`
`OBERMANN, Administrative Patent Judge.
`
`
`
`DECISION
`Granting Patent Owner’s Motion for
`Pro Hac Vice Admission of Adam L. Perlman
`37 C.F.R. § 42.10(c)
`
`
`
`IPR2017-01054
`Patent 8,268,299 B2
`
`
`On October 16, 2017, Patent Owner filed a motion for pro hac vice
`admission of Adam L. Perlman (Paper 10) supported by a declaration of
`Mr. Perlman (Exhibit 2001). Petitioner did not file an opposition. See Paper
`5, 2 (citing Unified Patents, Inc. v. Parallel Iron, LLC, Case IPR2013-00639
`(PTAB Oct. 15, 2013) (Paper 7) (setting a one week time period for filing an
`opposition to a motion for pro hac vice admission)). Based on our review of
`Patent Owner’s motion and Mr. Perlman’s declaration, we determine that
`Patent Owner establishes “good cause” for the admission.
`
`It is:
`ORDERED that Patent Owner’s motion for pro hac vice admission of
`Mr. Perlman is granted; Mr. Perlman is authorized to represent Patent
`Owner only as back-up counsel in the instant proceedings;
`FURTHER ORDERED that Patent Owner is to continue to have a
`registered practitioner represent it as lead counsel in the instant proceedings;
`FURTHER ORDERED that Mr. Perlman shall comply with the Office
`Patent Trial Practice Guide and the Board’s Rules of Practice for Trials, as
`set forth in Part 42 of Title 37, Code of Federal Regulations; and
`FURTHER ORDERED that Mr. Perlman shall be subject to the
`Office’s disciplinary jurisdiction under 37 C.F.R. § 11.19(a), and the
`USPTO Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et.
`seq.
`
`
`
`
`2
`
`
`
`IPR2017-01054
`Patent 8,268,299 B2
`
`PETITIONER:
`Michael R. Houston, Ph.D.
`Joseph P. Meara, Ph.D.
`James P. McParland, Ph.D.
`FOLEY & LARDNER LLP
`mhouston@foley.com
`jmeara-pgp@foley.com
`jmcparland@foley.com
`
`Tyler C. Liu
`ARGENTUM PHARMACEUTICALS LLC
`tliu@agpharm.com
`
`
`
`PATENT OWNER:
`
`David Krinsky
`Christopher Suarez
`WILLIAMS & CONNOLLY LLP
`dkrinsky@wc.com
`csuarez@wc.com
`
`
`
`
`3
`
`